These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 19116630

  • 1. Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow.
    Johnson MR, Verstovsek S, Jorgensen JL, Manshouri T, Luthra R, Jones DM, Bueso-Ramos CE, Medeiros LJ, Huh YO.
    Mod Pathol; 2009 Jan; 22(1):50-7. PubMed ID: 19116630
    [Abstract] [Full Text] [Related]

  • 2. Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease.
    Fernandes IC, Teixeira Mdos A, Freitas I, Selores M, Alves R, Lima M.
    An Bras Dermatol; 2014 Jan; 89(1):59-66. PubMed ID: 24626649
    [Abstract] [Full Text] [Related]

  • 3. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP.
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [Abstract] [Full Text] [Related]

  • 4. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
    Berezowska S, Flaig MJ, Ruëff F, Walz C, Haferlach T, Krokowski M, Kerler R, Petat-Dutter K, Horny HP, Sotlar K.
    Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
    [Abstract] [Full Text] [Related]

  • 5. Mastocytosis: state of the art.
    Horny HP, Sotlar K, Valent P.
    Pathobiology; 2007 Jan; 74(2):121-32. PubMed ID: 17587883
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.
    Morgado JM, Sánchez-Muñoz L, Teodósio CG, Jara-Acevedo M, Alvarez-Twose I, Matito A, Fernández-Nuñez E, García-Montero A, Orfao A, Escribano L.
    Mod Pathol; 2012 Apr; 25(4):516-21. PubMed ID: 22222639
    [Abstract] [Full Text] [Related]

  • 9. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
    Pardanani A.
    Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.
    Reichard KK, Chen D, Pardanani A, McClure RF, Howard MT, Kurtin PJ, Wood AJ, Ketterling RP, King RL, He R, Morice WG, Hanson CA.
    Am J Clin Pathol; 2015 Sep; 144(3):493-502. PubMed ID: 26276780
    [Abstract] [Full Text] [Related]

  • 12. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.
    Pardanani A.
    Am J Hematol; 2019 Mar; 94(3):363-377. PubMed ID: 30536695
    [Abstract] [Full Text] [Related]

  • 13. Mastocytosis and related disorders.
    Chiu A, Orazi A.
    Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
    Pardanani A.
    Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
    [Abstract] [Full Text] [Related]

  • 16. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
    Pardanani A.
    Am J Hematol; 2021 Apr 01; 96(4):508-525. PubMed ID: 33524167
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
    Pozdnyakova O, Kondtratiev S, Li B, Charest K, Dorfman DM.
    Am J Clin Pathol; 2012 Sep 01; 138(3):416-24. PubMed ID: 22912359
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.
    Sánchez-Muñoz L, Morgado JM, Álvarez-Twose I, Matito A, Garcia-Montero AC, Teodosio C, Jara-Acevedo M, Mayado A, Mollejo M, Caldas C, González de Olano D, Escribano L, Orfao A.
    Br J Haematol; 2016 Jan 01; 172(1):56-63. PubMed ID: 26456532
    [Abstract] [Full Text] [Related]

  • 20. Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group.
    Sotlar K, George TI, Kluin P, Reiter A, Schwaab J, Panse J, Brockow K, Hartmann K, Sperr WR, Kristensen T, Nedoszytko B, Carter M, Bonadonna P, Lyons JJ, Kluin-Nelemans HC, Hermine O, Akin C, Broesby-Olsen S, Hoermann G, Triggiani M, Butterfield JH, Jawhar M, Gotlib J, Metcalfe DD, Orfao A, Arock M, Valent P, Horny HP.
    J Allergy Clin Immunol Pract; 2022 Aug 01; 10(8):1986-1998.e2. PubMed ID: 35724949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.